Shanghai Haishun New Pharmaceutical Packaging Co Ltd Strategic Asset Allocation Index
Shanghai Haishun New Pharmaceutical Packaging Co Ltd strategic asset allocation index. Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) has a Strategic Asset Allocation Index of 43.1% as of June 2023. Strategic assets (PP&E of CN¥808.86 Million plus long-term investments of CN¥-) total CN¥808.86 Million, measured against net assets of CN¥1.88 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Shanghai Haishun New Pharmaceutical Pack tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2022)
Strategic asset allocation index of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2022. This chart shows how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 43.1%, representing strategic assets of CN¥808.86 Million against net assets of CN¥1.88 Billion CNY.
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Shanghai Haishun New Pharmaceutical Packaging Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300501 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 44.3% | CN¥744.48 Million | CN¥744.48 Million | CN¥- | CN¥1.68 Billion | ▲ +1.8 pp |
| 2021 | 42.5% | CN¥674.09 Million | CN¥674.09 Million | CN¥- | CN¥1.59 Billion | ▼ -12.4 pp |
| 2020 | 54.9% | CN¥481.29 Million | CN¥481.29 Million | CN¥- | CN¥876.40 Million | ▲ +11.1 pp |
| 2019 | 43.8% | CN¥334.18 Million | CN¥334.18 Million | CN¥- | CN¥762.37 Million | ▲ +0.6 pp |
| 2018 | 43.3% | CN¥309.29 Million | CN¥308.80 Million | CN¥482.61K | CN¥714.84 Million | ▲ +13.7 pp |
| 2017 | 29.6% | CN¥187.56 Million | CN¥187.56 Million | CN¥- | CN¥633.69 Million | ▲ +6.4 pp |
| 2016 | 23.2% | CN¥138.10 Million | CN¥138.10 Million | CN¥- | CN¥594.42 Million | ▼ -6.0 pp |
| 2015 | 29.3% | CN¥79.32 Million | CN¥79.32 Million | CN¥- | CN¥270.92 Million | ▼ -2.6 pp |
| 2014 | 31.9% | CN¥73.96 Million | CN¥73.96 Million | CN¥- | CN¥232.14 Million | ▼ -8.8 pp |
| 2013 | 40.7% | CN¥79.66 Million | CN¥79.66 Million | CN¥- | CN¥195.85 Million | ▼ -4.1 pp |
| 2012 | 44.8% | CN¥73.88 Million | CN¥73.88 Million | CN¥- | CN¥164.87 Million | ▼ -8.3 pp |
| 2011 | 53.1% | CN¥69.51 Million | CN¥69.51 Million | CN¥- | CN¥130.81 Million | — |